Full-Time

Account Manager

Sales

Posted on 9/25/2025

Deadline 9/24/26
BrightSpring Health Services

BrightSpring Health Services

10,001+ employees

Home-based and community health services, pharmacy

No salary listed

Atlanta, GA, USA

In Person

Category
Sales & Account Management (1)
Required Skills
Sales
Customer Service
Requirements
  • Associate degree or equivalent program from a two-year college or technical school, or certificate program in pharmacy and/or healthcare
  • Bachelor’s Degree desired
  • 2+ years’ healthcare or customer service experience preferred. Familiar with specialty providers, clinic, and hospital communities desired
  • Ability to respond to common inquiries or complaints from customers, employees, or senior management
  • Self-motivated and results driven
  • Highly effective in working objectively with a diverse group of people and must demonstrate communication, organizational, administrative and office skills
  • Maintain HIPAA patient confidentiality
  • Familiarity with general pharmacy terminology, brand, and generic names of medications preferred
  • Understanding drug reimbursement, Managed Care Medical Specialty and PBM drug benefits
  • Exceptional probing and consultative communication skills
  • Proficient in data entry, verbal skills, computer skills and the ability to learn the department’s software system including CRM
Responsibilities
  • Seeks out opportunities for prescriber experience process improvement and collaborates with Pharmacy OPS and outside sales to achieve prescriber experience improvement and sales goals
  • Achieves designated call expectations for assigned prescribers with a focus on top targets, key influencers, and pipeline leads
  • Responsible for identifying, ranking, prospecting, and developing key specialty practices and business relationships in neurology, immunology, and GI accounts within targeted regional territory
  • Assists with sales escalations and communicates routinely with field sales representative partner about details impacting prescriber or patient experience
  • Supports education and delivery of key messages and product presentations within initiatives (i.e. Selling our Success communication, drug launches, Medicare changes, etc.) designed to ensure territory meets performance requirements
  • Responsible for forwarding calls pertaining to clinical information and questions (i.e., dosing directions, adverse events, counseling, etc.) to Staff Pharmacists
  • Documents and meticulously makes notations in each patient’s profile and/or CRM regarding every update and aspect of a customer’s/physician’s care or needs
  • Uses discretion and independent judgment in handling customer complaints received, while documenting and forwarding to appropriate administrative staff
  • Obtains and manages prescriber communication preferences
  • Nurtures and manages prescriber relationships to improve loyalty, and retention
  • Utilizes RAMConnect Tool to ensure all account prescriptions are processed quickly and efficiently throughout the workflow process
  • Assists operations staff and prescriber offices with prior authorizations by following up on outstanding issues and assisting with coordination and communication
  • Ensure that prescription renewal requests are communicated in a timely manner to ensure continuity of care when applicable
  • Works collaboratively with sales to achieve monthly, quarterly, and annual sales goals
Desired Qualifications
  • Tech savvy
  • Experience in Admissions and/or Healthcare is a plus
BrightSpring Health Services

BrightSpring Health Services

View

BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.

Company Size

10,001+

Company Stage

Post IPO Equity

Headquarters

Louisville, Kentucky

Founded

1974

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.61B, up 26%, raising full-year guidance to $14.98B.
  • Amedisys and LHC acquisitions add 107 locations, contributing $30M EBITDA in 2026.
  • Sevita sale yields $811M cash for debt reduction and $2B M&A through 2028.

What critics are saying

  • Money Message ransomware stole 2M records including SSNs in March 2023 breach.
  • DOJ fined ResCare in October 2019 for fake Medicaid revaluations from 2009-2014.
  • Pomerantz investigates securities fraud by BrightSpring officers as of 2026.

What makes BrightSpring Health Services unique

  • BrightSpring integrates specialty pharmacy with home health for complex chronic care patients.
  • PharMerica dispenses 40 million prescriptions annually to 4 million patients.
  • Provider services target intellectual disabilities via home-based behavioral health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

Yahoo Finance
Apr 10th, 2026
BrightSpring Health shares jump 5.2% on 15-20% EBITDA growth targets and AI efficiency plans

BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.

Yahoo Finance
Mar 30th, 2026
BrightSpring Health Services stock surges 43% in 6 months, but low ROIC raises concerns

BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.

Yahoo Finance
Mar 25th, 2026
BrightSpring trades at 24.5x forward P/E despite $600M revenue headwinds

BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.

Yahoo Finance
Mar 24th, 2026
BrightSpring tops Q4 senior health earnings as Chemed's $639M revenue disappoints

BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.

Yahoo Finance
Mar 19th, 2026
BrightSpring projects sub-2x leverage in 2026, unveils $2B M&A firepower and integrated care strategy

BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.

INACTIVE